MR1 BIOCHEMICAL FEATURES AND IMMUNOLOGICAL FUNCTIONS

MR1 生化特征和免疫功能

基本信息

  • 批准号:
    8459413
  • 负责人:
  • 金额:
    $ 35.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-09-30 至 2015-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Elimination of pathogen-infected cells requires their sequential recognition by cells in the innate and acquired immune systems. A unique category of T cells collectively referred to as 'innate T cells' kinetically bridge the innate and acquired immune responses. Interestingly, the activation of innate T cells can be restricted by the expression of MHC-like molecules or class Ib molecules. The ability of innate T cells to respond rapidly stems from their lack of dependence on clonal expansion, resulting from less discriminating receptor-ligand interactions. By comparison, classical MHC molecules restrict conventional CD4 and CD8 T cells in the acquired immune response, and they require 10-14 days to clonally expand to sufficient numbers due to highly specific receptor-ligand interactions. The experiments in this grant will characterize the novel class Ib molecule MR1 that is evolutionarily conserved in mammals and restricts the development of mucosal-associated invariant T cells or MAIT cells in a manner dependent upon the commensal flora and B cells. MAIT cells have several features consistent with their function as innate T cells including i) invariant T cell receptor alpha chains, ii) the ability to rapidly release cytokines, and iii) apparent recognition of an evolutionarily conserved ligand. However, the nature of the MR1 ligand is unknown as is the physiological role of MAIT cells. In this application we will test whether MAIT cells detect Mycobacterium tuberculosis-infected cells and are critical components of host resistance to this pathogen. In addition, we will elucidate the nature of the MR1 ligand, the pathway by which it is presented, and the crystal structure of a ligand/MR1 complex. Cellular, molecular and structural dissection of MR1 antigen presentation to MAIT cells will critically define the mechanism and importance of this pathway in protective immunity to bacteria.
描述(由申请人提供):消除病原体感染的细胞需要它们被先天性和获得性免疫系统中的细胞顺序识别。统称为“先天性T细胞”的独特类别的T细胞在动力学上桥接先天性和获得性免疫应答。有趣的是,先天性T细胞的激活可以受到MHC样分子或Ib类分子表达的限制。先天性T细胞快速反应的能力源于它们缺乏对克隆扩增的依赖性,这是由较少的识别性受体-配体相互作用引起的。相比之下,经典的MHC分子在获得性免疫应答中限制常规的CD 4和CD 8 T细胞,并且由于高度特异性的受体-配体相互作用,它们需要10-14天来克隆扩增到足够的数量。在这项授权的实验将表征新的Ib类分子MR 1是进化上保守的哺乳动物和限制发展的粘膜相关的不变的T细胞或MAIT细胞的方式依赖于肠道植物群和B细胞。MAIT细胞具有与其作为先天性T细胞的功能一致的若干特征,包括i)不变的T细胞受体α链,ii)快速释放细胞因子的能力,和iii)进化上保守的配体的表观识别。然而,MR 1配体的性质是未知的,因为是MAIT细胞的生理作用。在本申请中,我们将测试MAIT细胞是否检测结核分枝杆菌感染的细胞,以及是否是宿主对该病原体的抗性的关键组成部分。此外,我们将阐明MR 1配体的性质,它是通过何种途径提出的,以及配体/MR 1复合物的晶体结构。MR 1抗原呈递给MAIT细胞的细胞、分子和结构解剖将严格定义该途径在细菌保护性免疫中的机制和重要性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daved H. Fremont其他文献

Structural basis for plasticity in receptor engagement by an encephalitic alphavirus
一种致脑炎甲病毒受体结合可塑性的结构基础
  • DOI:
    10.1016/j.cell.2025.02.036
  • 发表时间:
    2025-05-29
  • 期刊:
  • 影响因子:
    42.500
  • 作者:
    Saravanan Raju;Sathvik Palakurty;Alan Sariol;Ngan Wagoner;Lucas J. Adams;Sean Hui;William B. Klimstra;Daved H. Fremont;Michael S. Diamond
  • 通讯作者:
    Michael S. Diamond
A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in mice
  • DOI:
    10.1016/j.chom.2024.10.016
  • 发表时间:
    2024-12-11
  • 期刊:
  • 影响因子:
  • 作者:
    James Brett Case;Shilpa Sanapala;Carly Dillen;Victoria Rhodes;Christian Zmasek;Taras M. Chicz;Charlotte E. Switzer;Suzanne M. Scheaffer;George Georgiev;Catherine Jacob-Dolan;Blake M. Hauser;Déborah Carolina Carvalho Dos Anjos;Lucas J. Adams;Nadia Soudani;Chieh-Yu Liang;Baoling Ying;Ryan P. McNamara;Richard H. Scheuermann;Adrianus C.M. Boon;Daved H. Fremont
  • 通讯作者:
    Daved H. Fremont
136 Herpesvirus Entry Mediator and Cytomegalovirus ORF UL144 Bind a Common Region of B And T Lymphocyte Attenuator
  • DOI:
    10.1016/j.cyto.2007.07.141
  • 发表时间:
    2007-07-01
  • 期刊:
  • 影响因子:
  • 作者:
    John R. Sedy;Christopher A. Nelson;Paula S. Norris;Kenneth M. Murphy;Chris A. Benedict;Daved H. Fremont;Carl F. Ware
  • 通讯作者:
    Carl F. Ware
Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect against Spondweni Virus Infection and Pathogenesis in Mice
  • DOI:
    10.1016/j.celrep.2019.01.052
  • 发表时间:
    2019-02-05
  • 期刊:
  • 影响因子:
  • 作者:
    Vanessa Salazar;Brett W. Jagger;Juthathip Mongkolsapaya;Katherine E. Burgomaster;Wanwisa Dejnirattisai;Emma S. Winkler;Estefania Fernandez;Christopher A. Nelson;Daved H. Fremont;Theodore C. Pierson;James E. Crowe;Gavin R. Screaton;Michael S. Diamond
  • 通讯作者:
    Michael S. Diamond
Toxoplasma Gondii Actin Assembles via Isodesmic Polymerization
  • DOI:
    10.1016/j.bpj.2012.11.3563
  • 发表时间:
    2013-01-29
  • 期刊:
  • 影响因子:
  • 作者:
    Kristen M. Skillman;Christopher Ma;Karthikeyan Diraviyam;Daved H. Fremont;John A. Cooper;L. David Sibley;David Sept
  • 通讯作者:
    David Sept

Daved H. Fremont的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daved H. Fremont', 18)}}的其他基金

Structure and Function of Proxvirus Immune Evasion Domains
Proxvirus 免疫逃避结构域的结构和功能
  • 批准号:
    9012755
  • 财政年份:
    2016
  • 资助金额:
    $ 35.36万
  • 项目类别:
Viral evasion of IFN function by decoy receptor sequestration
病毒通过诱饵受体隔离来逃避干扰素功能
  • 批准号:
    8234940
  • 财政年份:
    2011
  • 资助金额:
    $ 35.36万
  • 项目类别:
Viral evasion of IFN function by decoy receptor sequestration
病毒通过诱饵受体隔离来逃避干扰素功能
  • 批准号:
    7672148
  • 财政年份:
    2009
  • 资助金额:
    $ 35.36万
  • 项目类别:
Immune Evasion Mechanisms of Ectromelia Virus
湿疣病毒的免疫逃避机制
  • 批准号:
    7641548
  • 财政年份:
    2008
  • 资助金额:
    $ 35.36万
  • 项目类别:
Subproject #7
子项目
  • 批准号:
    7099073
  • 财政年份:
    2005
  • 资助金额:
    $ 35.36万
  • 项目类别:
STRUCTURAL STUDIES OF IMMUNOLOGICAL PROCESSES
免疫过程的结构研究
  • 批准号:
    6978134
  • 财政年份:
    2004
  • 资助金额:
    $ 35.36万
  • 项目类别:
Viral Decoy Receptors
病毒诱饵受体
  • 批准号:
    6986782
  • 财政年份:
    2002
  • 资助金额:
    $ 35.36万
  • 项目类别:
Viral Decoy Receptors
病毒诱饵受体
  • 批准号:
    6829093
  • 财政年份:
    2002
  • 资助金额:
    $ 35.36万
  • 项目类别:
Viral Decoy Receptors
病毒诱饵受体
  • 批准号:
    6581065
  • 财政年份:
    2002
  • 资助金额:
    $ 35.36万
  • 项目类别:
Viral Decoy Receptors
病毒诱饵受体
  • 批准号:
    7152884
  • 财政年份:
    2002
  • 资助金额:
    $ 35.36万
  • 项目类别:

相似海外基金

Characterizing RNA regulation in B lymphocytes
B 淋巴细胞中 RNA 调控的特征
  • 批准号:
    502601
  • 财政年份:
    2024
  • 资助金额:
    $ 35.36万
  • 项目类别:
B Lymphocytes in Autoimmune Disease
自身免疫性疾病中的 B 淋巴细胞
  • 批准号:
    10370125
  • 财政年份:
    2022
  • 资助金额:
    $ 35.36万
  • 项目类别:
Characterization of Streptococcus suis interactions with B lymphocytes
猪链球菌与 B 淋巴细胞相互作用的表征
  • 批准号:
    573206-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 35.36万
  • 项目类别:
    University Undergraduate Student Research Awards
Myocardial-associated B lymphocytes and inflammatory injury
心肌相关B淋巴细胞与炎症损伤
  • 批准号:
    10543825
  • 财政年份:
    2022
  • 资助金额:
    $ 35.36万
  • 项目类别:
Altered B lymphocytes Due to Tungstate Exposure
钨酸盐暴露导致 B 淋巴细胞发生改变
  • 批准号:
    RGPIN-2020-05899
  • 财政年份:
    2022
  • 资助金额:
    $ 35.36万
  • 项目类别:
    Discovery Grants Program - Individual
The regulation of signaling and cytoskeletal rearrangements in B-lymphocytes
B 淋巴细胞信号传导和细胞骨架重排的调节
  • 批准号:
    RGPIN-2019-04911
  • 财政年份:
    2022
  • 资助金额:
    $ 35.36万
  • 项目类别:
    Discovery Grants Program - Individual
Myocardial-associated B lymphocytes and inflammatory injury
心肌相关B淋巴细胞与炎症损伤
  • 批准号:
    10339541
  • 财政年份:
    2022
  • 资助金额:
    $ 35.36万
  • 项目类别:
Exploring RNA helicase DDX the role of the1 at the crossroad of DNA repair processes in B lymphocytes
探索 RNA 解旋酶 DDX 在 B 淋巴细胞 DNA 修复过程十字路口的作用
  • 批准号:
    BB/X511560/1
  • 财政年份:
    2022
  • 资助金额:
    $ 35.36万
  • 项目类别:
    Training Grant
Role and regulation of extracellular vesicles generated in response to stimulation of CD24 on B lymphocytes
B 淋巴细胞上 CD24 刺激产生的细胞外囊泡的作用和调节
  • 批准号:
    RGPIN-2022-03800
  • 财政年份:
    2022
  • 资助金额:
    $ 35.36万
  • 项目类别:
    Discovery Grants Program - Individual
B Lymphocytes in Autoimmune Disease
自身免疫性疾病中的 B 淋巴细胞
  • 批准号:
    10640819
  • 财政年份:
    2022
  • 资助金额:
    $ 35.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了